| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| R&D Expense | $848K | -87.3% |
| SG&A Expense | $7.7M | +43.1% |
| Operating Income | -$8.4M | +29.8% |
| Pre-tax Income | -$3.0M | +75.1% |
| Income Tax | $7K | +100.9% |
| Net Income | -$3.0M | +73.3% |
| EPS (Basic) | -$6.45 | -208.6% |
| EPS (Diluted) | -$6.45 | -208.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.5M | +11.7% |
| Accounts Receivable | $1.3M | — |
| Inventory | $1.4M | — |
| Current Assets | $6.3M | +70.3% |
| Total Assets | $8.2M | +99.9% |
| Current Liabilities | $1.3M | -78.7% |
| Total Liabilities | $1.3M | -78.6% |
| Stockholders' Equity | $6.8M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.8M | +40.3% |
| Financing Cash Flow | $5.3M | -32.7% |
| +414.7% |